Brief: Astrazeneca Pharma India Confirms Restructuring Of Biopharmaceutical Team
30/12/2024 06:57
Dec 30 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* CONFIRMS RESTRUCTURING OF BIOPHARMACEUTICAL TEAM
* RESTRUCTURING OF BIOPHARMACEUTICAL TEAM IMPACTING CERTAIN
ROLES
Further company coverage: ASTR.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication